Posted in | News | Business

ZEISS and University of California Berkeley Launch Public-Private Partnership to Support Brain Microscopy Innovation Center

ZEISS announces that it is participating in a new public-private partnership with UC Berkeley as part of the Brain Microscopy Innovation Center (BrainMIC), a component of the Berkeley BRAIN Initiative.

The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was launched by President Obama in 2013 and is focused on revolutionizing understanding of the human brain, with the goal of helping researchers uncover the mysteries of such brain disorders as Alzheimer’s and Parkinson’s diseases, depression, and traumatic brain injury.

As part of the initiative, ZEISS has delivered a variety of high performance microscopes and imaging systems. Equipment installed in phase one of the multi-phase project includes ZEISS LSM 880 with Airyscan multiphoton confocal microscope, ZEISS LSM 880 confocal microscope with OPO capabilities, as well as ZEISS Lightsheet Z.1 light sheet imaging system with special optics for cleared tissue samples, and ZEISS Axio Scan.Z1 digital slide scanning system.

As part of the partnership, ZEISS will provide the latest updates of the equipment, while UC Berkeley researchers will offer feedback on any new or special neurotechnology needs to help ZEISS produce future products best suited for the newest advances in neuroscience research endeavors.

The public-private initiative was launched on May 28, 2015 at an event hosted by UC Berkeley. James Sharp, President of ZEISS Microscopy USA, spoke at the event, along with Ehud Isacoff, Director of the Helen Wills Neuroscience Institute, Holly Aaron, Manager of the BrainMIC, Steven Martin, Dean of Biological Sciences and Sharif Taha, Scientific Program Officer at The Kavli Foundation.

According to Holly Aaron, the BrainMIC was established as a resource for the neuroscience community, with the goal of overcoming one of the BRAIN Initiative’s major challenges – making new tools accessible to the broad community. “There has been a rapid advance in the optical tools available to detect and control neuronal activity and synaptic transmission.

These powerful tools are an important and exciting step toward deciphering the neuronal circuits that command essential brain functions, such as perception, movement, and memory. However, for these tools to yield breakthrough discoveries there is a need for commercially available microscopes that are optimized for use with emerging neurotechnologies.

ZEISS’s participation will help us meet that need.” Sharp added: “I am very excited about the partnership and looking forward to discussions about the types of research UC Berkeley is pursuing and helping researchers use the equipment to its fullest capabilities, while at the same time helping ZEISS to increase our capabilities.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Carl Zeiss Microscopy GmbH. (2019, March 18). ZEISS and University of California Berkeley Launch Public-Private Partnership to Support Brain Microscopy Innovation Center. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=43983.

  • MLA

    Carl Zeiss Microscopy GmbH. "ZEISS and University of California Berkeley Launch Public-Private Partnership to Support Brain Microscopy Innovation Center". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=43983>.

  • Chicago

    Carl Zeiss Microscopy GmbH. "ZEISS and University of California Berkeley Launch Public-Private Partnership to Support Brain Microscopy Innovation Center". AZoM. https://www.azom.com/news.aspx?newsID=43983. (accessed November 21, 2024).

  • Harvard

    Carl Zeiss Microscopy GmbH. 2019. ZEISS and University of California Berkeley Launch Public-Private Partnership to Support Brain Microscopy Innovation Center. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=43983.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.